-+ 0.00%
-+ 0.00%
-+ 0.00%

ZAI LAB RECEIVES CHINA NMPA APPROVAL OF TIVDAK® (TISOTUMAB VEDOTIN FOR INJECTION) FOR THE TREATMENT OF ADULT PATIENTS WITH RECURRENT OR METASTATIC CERVICAL CANCER

Reuters·06/09/2026 00:34:00

Please log in to view news